Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Enrollment completed in pivotal phase III trial of Chondrogel

Sep. 21, 2000

Sanofi-Synthelabo discloses synthesis and use of new alpha-azacyclomethylquinolines

Sep. 19, 2000

Preclinical results in guinea pigs suggest novel mechanism of action for TAK-637

Sep. 18, 2000

Update on U.S. status of Zonagen's sexual dysfunction products

Sep. 15, 2000

Cystistat approved for expanded indications in Europe

Sep. 14, 2000

Renal I/R injury prevented by VAS-971 therapy in canine model

Sep. 14, 2000

Arch scientists discover new peptides with mitogenic properties

Sep. 12, 2000

New polyazanaphthalenones for BPH

Sep. 8, 2000

Merck's focus on more effective and safe agents for BPH continues

Sep. 8, 2000

Ditropan XL and Detrol produce similar incidence of dry mouth

Sep. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...